Optic Neuritis Treatment Market Trends

  • Report ID: 4174
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Optic Neuritis Treatment Market Trends

Growth Drivers

  • Spiking Cases of Blindness across the Globe- Optic neuritis (ON) is a disorder that affects the eye and your vision when the nerve to the eye gets inflamed. Moreover, blindness or vision loss of one eye is a symptom of optic neuritis and it can be treated with optic neuritis treatment, this drives the growth of the market. The number of people who are losing their vision is rising, and it is predicted that over the next 30 years, eyesight loss is predicted to rise by over 50% across the globe.
  • Growing Cases of Autoimmune Disorders- This autoimmune disorder such as multiple sclerosis causes immune system cells and antibodies to attack the optic nerves and may cause damage. Optic neuritis is a common visual symptom of multiple sclerosis; the lifetime chance of acquiring multiple sclerosis is over 45% following one episode of optic neuritis.

Challenges

  • Side Effects of Treatment such as Weight Gain, Increased Blood Pressure, and Others- This treatment has its benefits however it also does have some side effects which include weight gain, increased blood pressure, and others, which are especially seen in the geriatric population.
  • Lack of Requisite Awareness of the Treatment
  • Increment in the Utilization of Prednisolone Prednisone

Optic Neuritis Treatment Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5.5%

Base Year Market Size (2023)

USD 232.1 Million

Forecast Year Market Size (2036)

USD 465.54 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4174
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of optic neuritis treatment is assessed at USD 243.59 Million.

The optic neuritis treatment market size was over USD 232.1 Million in 2023 and is poised to reach USD 465.54 Million by the end of 2036, growing at around 5.5% CAGR during the forecast period i.e., between 2024-2036. Rising incidences of bacterial infections across the globe and the significant increment in global geriatric population are the major factors driving the growth of the market.

North America is predicted to account for the largest share of 35% by 2036, impelled by higher adoption of steroids in the region.

Santen Pharmaceutical Co., Ltd., Mallinckrodt plc, AbbVie Inc., Novartis AG, Sanofi-aventis Groupe, AdvoCare International, Hikma Pharmaceuticals PLC, Henry Schein, Inc., Fresenius Kabi USA, Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample